Skip to main content
. 2011 Aug 9;20(R2):R132–R141. doi: 10.1093/hmg/ddr349

Table 1.

Recent timeline of DTC genetic testing events

Year Month Event
2010 March NIH announced creation of Genetic Testing Registry to be launched in 2011
May Pathway Genomics announced Walgreens partnership to sell genetic testing kit at over 6000 retail stores
FDA notified Pathway that kit appeared to meet criteria for medical device, and thus required FDA approval
June FDA sends similar letter to five other companies (Knome, Navigenics, deCODE, 23andMe, Illumina)
July FDA sends similar letter to 15 additional DTC companies
FDA holds public meeting on how the Agency should regulate LDTs
Congressional Committee holds hearing on ‘DTC Genetic Testing and Consequences to the Public Health’
GAO report on DTC genetic testing and ‘sting’ operation released
2011 February AMA sends letter to FDA suggesting that all genetic testing be done under the guidance of a physician
March FDA holds meeting to discuss the regulation of DTC genetic testing (Molecular and Clinical Genetics Panel)
May FDA sends letter to three additional DTC companies